Tragically, sarcoma will return for one in three children even after surgery to remove the cancer - this high rate of relapse after treatment is a major cause of fatality. But with your kind support, Dr Ben Wylie and his team in Western Australia are developing a ground-breaking new treatment aiming to change that.
A generous grant of $91,000 made by Perpetual Trustees to The Kids' Cancer Project will help to fund a pioneering research project aiming to identify the 'culprit' genes behind childhood cancer.
July marks Sarcoma Awareness Month, a time when we shine a light on a cancer responsible for about 20% of childhood cancer diagnoses. Thanks to the ongoing commitment of our wonderful community, The Kids' Cancer Project is actively funding nine projects across Australia in order to develop better treatment options for those kids.
With a background in immunology, Dr Tessa Gargett is utilising her knowledge of the human immune system to tackle children’s cancer. Here, she explains how she’s maximising the potential of CAR-T cells to provide a treatment option specifically tailored to brain tumours.
Diffuse midline gliomas (DMG), including diffuse intrinsic pontine gliomas (DIPG), are the most lethal of childhood cancers primarily occurring in young children.
The Zero Childhood Cancer Program (ZERO), which has been supported by The Kids’ Cancer Project since 2015, is being expanded to all Australian's aged 0 to 18 years with any type of cancer.
The study which developed the revolutionary clinical guidelines was co-funded by The Kids' Cancer Project, led by researchers from the Murdoch Children's Research Institute, and endorsed by the Australian and New Zealand Children's Oncology Group.